The PARP inhibitor olaparib potentiates the effect of the DNA damaging agent doxorubicin in osteosarcoma
2018 · Journal of Experimental & Clinical Cancer Research · 96 citations
https://doi.org/10.1186/s13046-018-0772-9
K
Kyoung Min Kim
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
90
Papers
1.9K
Citations
24
h-index
43
i10-index
Kyoung Min Kim is an academic researcher from Jeonbuk National University Hospital. The author has contributed to research in topics: PARP inhibition in cancer therapy & Sirtuins and Resveratrol in Medicine & Genetic factors in colorectal cancer. The author has an h-index of 24, co-authored 77 publications.
Papers by this author
worksClinical significance of p53 protein expression and TP53 variation status in colorectal cancer
2022 · BMC Cancer · 78 citations
https://doi.org/10.1186/s12885-022-10039-y
FAM83H is involved in stabilization of β-catenin and progression of osteosarcomas
2019 · Journal of Experimental & Clinical Cancer Research · 58 citations
https://doi.org/10.1186/s13046-019-1274-0
Expression of DNA Damage Response Molecules PARP1, γH2AX, BRCA1, and BRCA2 Predicts Poor Survival of Breast Carcinoma Patients
2015 · Translational Oncology · 23 citations
https://doi.org/10.1016/j.tranon.2015.04.004
A primary pure pancreatic-type acinar cell carcinoma of the stomach: a case report
2017 · Diagnostic Pathology · 20 citations
https://doi.org/10.1186/s13000-017-0601-z
Primary malignant melanoma arising from ruptured ovarian mature cystic teratoma with elevated serum CA 19–9: a case report and review of literature
2019 · BMC Women s Health · 14 citations
https://doi.org/10.1186/s12905-019-0853-8
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat